Cellenkos, Inc.
www.cellenkosinc.comCellenkos is an early stage clinical biotechnology company that focuses on umbilical cord blood derived T-regulatory cellular therapies for treating autoimmune diseases and inflammatory disorders.
Read more
Cellenkos is an early stage clinical biotechnology company that focuses on umbilical cord blood derived T-regulatory cellular therapies for treating autoimmune diseases and inflammatory disorders.
Read more
Country
State
Texas
City (Headquarters)
Houston
Industry
Employees
11-50
Founded
2016
Estimated Revenue
$1,000,000 to $5,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Founder
Email ****** @****.comPhone (***) ****-****Chief Operating Officer
Email ****** @****.comPhone (***) ****-****Manager of Quality Control and Materials Management
Email ****** @****.comPhone (***) ****-****Clinical Manufacturing Quality Assurance and Regulatory Manager
Email ****** @****.comPhone (***) ****-****
Technologies
(3)
Reach decision makers at Cellenkos, Inc.
Free credits every month!
Cellenkos, Inc. FAQ
Houston, United States
Biotechnology Research
